Efficacy and safety of outpatient fludarabine, cyclophosphamide, and rituximab based allogeneic hematopoietic cell transplantation in adults with severe aplastic anemia
R.M. Gilmore(Vanderbilt University Medical Center), Katie S. Gatwood(Vanderbilt University Medical Center), Reena Jayani(Vanderbilt University), Adetola A. Kassim(Vanderbilt University), Elizabeth McNeer(Vanderbilt University Medical Center), Leena Choi, Bhagirathbhai Dholaria(Vanderbilt University Medical Center), Tae Kon Kim(Vanderbilt University), Karin Abernathy(Centennial Medical Center), Wichai Chinratanalab(VA Tennessee Valley Healthcare System), Dwight D. Eplin(VA Northeast Ohio Healthcare System), Salyka Sengsayadeth(VA Tennessee Valley Healthcare System), Bipin N. Savani(Vanderbilt University Medical Center), Kendall C. Shultes(Unknown), Lindsay Orton(Vanderbilt University)
Cited by 2
Related Papers
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|435
Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation
|Biology of Blood and Marrow Transplantation|2015|409
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States
|Blood|2017|296
Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation
|Biology of Blood and Marrow Transplantation|2014|210
Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients
|Bone Marrow Transplantation|2020|202